SETD4 Confers Cancer Stem Cell Chemoresistance in Nonsmall Cell Lung Cancer Patients via the Epigenetic Regulation of Cellular Quiescence
Increasing evidence indicates that quiescent cancer stem cells (CSCs) are a root cause of chemoresistance. SET domain-containing protein 4 (SETD4) epigenetically regulates cell quiescence in breast cancer stem cells (BCSCs), and SETD4-positive BCSCs are chemoradioresistant. However, the role of SETD...
Saved in:
Main Authors: | Yuehong Wang (Author), Yuman Yu (Author), Weijun Yang (Author), Linying Wu (Author), Yaoshun Yang (Author), Qianyun Lu (Author), Jianying Zhou (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy
by: Wanyin Chen, et al.
Published: (2016) -
Mitotic quiescence in hepatic cancer stem cells: An incognito mode
by: Kandasamy Ashokachakkaravarthy, et al.
Published: (2020) -
Prognostic Impact of Sphingosine Kinase 1 in Nonsmall Cell Lung Cancer
by: Nozomu Motono, et al.
Published: (2021) -
Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed
by: Steven F Powell, et al.
Published: (2009) -
Metformin Delays Satellite Cell Activation and Maintains Quiescence
by: Theodora Pavlidou, et al.
Published: (2019)